FLGT Q3 2017 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$449M

Q3 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$5M-10.1% YoY

Gross Profit

$2M49.6% margin

Operating Income

-$1M-32.9% margin

Net Income

-$1M-24.3% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

-3.0%

Cash Flow

Operating Cash Flow

$500,000

Free Cash Flow

-$2M

Stock-Based Comp.

$549,000

Balance Sheet

Total Assets

$59M

Total Liabilities

$3M

Stockholders' Equity

$55M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$5M	-10.1%
Gross Profit	$2M	$3M	-22.1%
Operating Income	-$1M	-$695,000	-113.1%
Net Income	-$1M	-$1M	+1.3%

Geographic Segments

UNITED STATES

$2M49%

CANADA

$937,00021%

Other Countries

$814,00018%

CHINA

$561,00012%